Siemens Healthineers raises 2022 outlook on need for COVID-19 checks By Reuters

2/2

© Reuters. FILE Photograph: An worker donning a deal with mask is observed at a workshop of computed tomography (CT) scanners of healthcare product company Siemens Healthineers in Shanghai, China, February 24, 2020. REUTERS/Aly Track

2/2

(Corrects to present profits rose in next quarter, not initially quarter, of 2022 economical 12 months in paragraph 1)

BERLIN (Reuters) – U.S.-German health care unit maker Siemens Healthineers lifted its targets for the 2022 economical yr on Wednesday because of to greater desire for swift COVID-19 antigen assessments, and noted a increase in next-quarter profits and earnings.

The corporation said it now predicted its diagnostics segment to create close to 1.3 billion euros ($1.37 billion) in income with swift COVID-19 antigen exams, up from some 700 million euros previously.

As a consequence, it predicted similar earnings development of among 5.5% and 7.5%, up from 3% to 5% formerly, and adjusted standard earnings for every share of among 2.25 and 2.35 euros, up from 2.18 to 2.30 euros previously.

“Our company proceeds to present great resilience in the confront of unprecedented issues. On this basis, and many thanks to superior need for our quick antigen checks, we are boosting our outlook for the present monetary 12 months,” CEO Bernd Montag claimed.

(Corrects to present earnings rose in second quarter, not very first quarter, of 2022 money 12 months in paragraph 1)